Prellis Biologics
VerifiedPrellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$140—210m (Dealroom.co estimates Aug 2022.)
San Francisco California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor investor investor investor investor investor | $0.0 | round | |
N/A | Series C | ||
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Prellis Biologics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.